Protein inhibitor could be new treatment for liver cancer
US scientists have found strong evidence for testing VCU-manufactured drugs in liver cancer.
List view / Grid view
US scientists have found strong evidence for testing VCU-manufactured drugs in liver cancer.
Using DNA barcoding to track cancer cells through time, scientists have shown that the cells have diverse abilities to escape the immune system.
Researchers show how monkeypox mutations cause virus to replicate, spread faster.
UPF and John Hopkins scientists have discovered how cancer cells exposed to high viscosity environments change their movements to improve their invasiveness and favour metastases.
Scientists have generated polygenic risk scores for developing paediatric steroid sensitive nephrotic syndrome (pSSNS), a kidney disease in children.
Spanish researchers have discovered that vitamin C may hold the key to improving the efficacy of dendritic cell-derived anticancer therapies.
The NPGPx protein is active in foetuses, but largely dormant and absent in diabetic adults.
Researchers have streamlined the traditionally slow process of enzyme engineering. This work might help researchers tailor the suitability of enzymes for custom purposes.
The College of American Pathologists has given accreditation to Altasciences’ clinical site in Los Angeles, California.
MIT researchers have developed a technique that could help the production of monoclonal antibodies and other useful proteins.
Researchers from the University of California have developed the first pre-clinical model of appendiceal cancer, containing all elements of the tumour.
The researchers used a zebrafish model to test mutations in Mycn, a gene which causes Feingold syndrome.
A recent study in mice revealed that an ion channel already proven to affect blood pressure in obese mice plays a role in suppressing their breathing, influencing sleep apnoea.
The study’s findings have important implications for better understanding the neurological basis for ASD and developing effective therapies for patients.
Researchers have used AI to design microneedle patches that restore hair in balding mice.